PIA
CCXI

Piedmont Investment Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Piedmont Investment Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-381
Closed -$5K – 2535
2018
Q2 		$5K Buy
+381
New +$4.56K ﹤0.01% 2171

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Piedmont Investment Advisors's CCXI Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q3 2018, closing a stake of 381 shares — an estimated $5K sold.

Piedmont Investment Advisors first reported a position in CCXI in Q2 2018 and held it in 1 quarter. The position peaked at $5K in Q2 2018. 106 funds tracked by Wall St. Rank hold CCXI as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining ChemoCentryx, Inc. position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 381 ChemoCentryx, Inc. shares in Q3 2018, an estimated $5K.
  • Piedmont Investment Advisors first reported a position in ChemoCentryx, Inc. in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's ChemoCentryx, Inc. position peaked at $5K in Q2 2018.
  • 106 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.